NCT03321370 Cortical Spreading Depolarization After Severe Traumatic Brain Injury
| NCT ID | NCT03321370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samuel Cramer |
| Condition | Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2019-08-14 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2019-08-14 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Preliminary evaluation of electrodes placed on the brain for recording brain activity and novel algorithms to determine cortical spreading depolarization foci of origination following severe traumatic brain injury requiring neurosurgical intervention.
Eligibility Criteria
Inclusion Criteria: * Patient recommended to undergo craniectomy or craniotomy for the treatment of acute TBI Exclusion Criteria: * Wound determined to be contaminated * Decompression is performed only in the posterior fossa * Known systemic infection * Pregnancy
Contact & Investigator
Samuel W Cramer, MD, PhD
PRINCIPAL INVESTIGATOR
University of Minnesota Neurosurgery Department; Division of Neurosurgery, Department of Surgery, Hennepin County Medical Center
Frequently Asked Questions
Who can join the NCT03321370 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03321370 currently recruiting?
Yes, NCT03321370 is actively recruiting participants. Contact the research team at rnl@umn.edu for enrollment information.
Where is the NCT03321370 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT03321370 clinical trial?
NCT03321370 is sponsored by Samuel Cramer. The principal investigator is Samuel W Cramer, MD, PhD at University of Minnesota Neurosurgery Department; Division of Neurosurgery, Department of Surgery, Hennepin County Medical Center. The trial plans to enroll 10 participants.